Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Notice of Incomplete Referencing

Notice of Incomplete Referencing As the Editor of the Archives of Neurology, I am writing to inquire about your article titled “Cross-reactive T-Cell Receptors in Tumor and Paraneoplastic Target Tissue,” which was published in the May 2009 issue of the Archives.1 You recently wrote to the Editor of The Journal of the Neurological Sciences (JNS) that: “I wanted to let you know that we have used biological material from the patient described in full detail in our paper 10974 in another paper just appearing in Arch Neurol (attached). In that paper we report CDR3 spectratyping data of tumor and CNS. However, in the “methods” section, we very briefly scratch the clinical scenario so readers understand the CDR3 data presented. We have always felt that this would not be a problem.” Actually, there is a problem, which requires a candid explanation from you so I can make a judgment about how this happened and what should be reported to our readers. The JNS article was accepted August 6, 2008, and the Archives of Neurology article was accepted October 1, 2008. The 2 articles shared biological material from 1 patient, which was not disclosed to the Archives. In addition to making a timely, voluntary disclosure to me and my editors, your article should have included a reference to the JNS article. Both the disclosure of the duplicate biological material and the reference to the JNS article in the Archives article should have been made to us before publication. These facts may have influenced our decision to accept and publish your study in our journal, and most certainly would have been shared with our readers. The AMA Manual of Style sections 5.3 and 5.3.2 indicate that you should have informed and consulted me about these facts when you submitted your manuscript.2 You apparently had months to alert and consult me between the time of acceptance by JNS and publication in that journal on May 15, 2009. We are grateful that Raymond Voltz, MD, the only author of both articles, revealed this lack of disclosure now, but we require a full explanation to set the record straight in our journal. The Archives of Neurology takes duplicate publication and the concurrent submission of studies seriously, so we require an explanation, and perhaps an apology, depending on the circumstances. A timely response to this letter would be appreciated. We often contact the appropriate Dean and all coauthors in an effort to fully clarify and rectify the situation, so your initial, thorough explanation would help us resolve the matter as we determine what should be reported to our readers. Correspondence: Dr Rosenberg, Department of Neurology, the University ot Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390-9108 (archneurol@jama-archives.org). Financial Disclosure: None reported. References 1. Pellkofer HLVoltz RGoebels NHohlfeld RDornmair K Cross-reactive T-cell receptors in tumor and paraneoplastic target tissue. Arch Neurol 2009;66 (5) 655- 658PubMedGoogle ScholarCrossref 2. Flanagin A Duplicate publication. Iverson CChristiansen SFlanagin A et al. AMA Manual of Style: A Guide for Authors and Editors. 10th ed. Chicago, IL Oxford University Press2007;148- 155Google Scholar http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Neurology American Medical Association

Notice of Incomplete Referencing

Archives of Neurology , Volume 66 (10) – Oct 12, 2009

Loading next page...
 
/lp/american-medical-association/notice-of-incomplete-referencing-T63Ylc0hZf
Publisher
American Medical Association
Copyright
Copyright © 2009 American Medical Association. All Rights Reserved.
ISSN
0003-9942
eISSN
1538-3687
DOI
10.1001/archneurol.2009.215
Publisher site
See Article on Publisher Site

Abstract

As the Editor of the Archives of Neurology, I am writing to inquire about your article titled “Cross-reactive T-Cell Receptors in Tumor and Paraneoplastic Target Tissue,” which was published in the May 2009 issue of the Archives.1 You recently wrote to the Editor of The Journal of the Neurological Sciences (JNS) that: “I wanted to let you know that we have used biological material from the patient described in full detail in our paper 10974 in another paper just appearing in Arch Neurol (attached). In that paper we report CDR3 spectratyping data of tumor and CNS. However, in the “methods” section, we very briefly scratch the clinical scenario so readers understand the CDR3 data presented. We have always felt that this would not be a problem.” Actually, there is a problem, which requires a candid explanation from you so I can make a judgment about how this happened and what should be reported to our readers. The JNS article was accepted August 6, 2008, and the Archives of Neurology article was accepted October 1, 2008. The 2 articles shared biological material from 1 patient, which was not disclosed to the Archives. In addition to making a timely, voluntary disclosure to me and my editors, your article should have included a reference to the JNS article. Both the disclosure of the duplicate biological material and the reference to the JNS article in the Archives article should have been made to us before publication. These facts may have influenced our decision to accept and publish your study in our journal, and most certainly would have been shared with our readers. The AMA Manual of Style sections 5.3 and 5.3.2 indicate that you should have informed and consulted me about these facts when you submitted your manuscript.2 You apparently had months to alert and consult me between the time of acceptance by JNS and publication in that journal on May 15, 2009. We are grateful that Raymond Voltz, MD, the only author of both articles, revealed this lack of disclosure now, but we require a full explanation to set the record straight in our journal. The Archives of Neurology takes duplicate publication and the concurrent submission of studies seriously, so we require an explanation, and perhaps an apology, depending on the circumstances. A timely response to this letter would be appreciated. We often contact the appropriate Dean and all coauthors in an effort to fully clarify and rectify the situation, so your initial, thorough explanation would help us resolve the matter as we determine what should be reported to our readers. Correspondence: Dr Rosenberg, Department of Neurology, the University ot Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390-9108 (archneurol@jama-archives.org). Financial Disclosure: None reported. References 1. Pellkofer HLVoltz RGoebels NHohlfeld RDornmair K Cross-reactive T-cell receptors in tumor and paraneoplastic target tissue. Arch Neurol 2009;66 (5) 655- 658PubMedGoogle ScholarCrossref 2. Flanagin A Duplicate publication. Iverson CChristiansen SFlanagin A et al. AMA Manual of Style: A Guide for Authors and Editors. 10th ed. Chicago, IL Oxford University Press2007;148- 155Google Scholar

Journal

Archives of NeurologyAmerican Medical Association

Published: Oct 12, 2009

Keywords: disclosure,neurology,neoplasms

References